Hexyl nicotinoate

We are Hexyl nicotinoate CAS:23597-82-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 23597-82-2
Product Name: Hexyl nicotinoate
Other Name:
Hexyl nicotinoate
Hexyl pyridine-3-carboxylate
N-hexyl nicotinoate
Nicotinsaeure-hexylester
Nicotinic Acid Hexyl Ester
3-Hexyloxycarbonylpyridine
 
Density: 1,02 g/cm3
Boiling Point: 140°C
Molecular Formula: C12H17NO2
Molecular Weight: 207.26900
Flash Point: 140ºC
Exact Mass: 207.12600
PSA: 39.19000
LogP: 2.81870
Vapour Pressure: 0.000181mmHg at 25°C
Index of Refraction: 1.495
 
Specification
Appearance: White Powder
Assay: ≥98.0%
Loss on drying: ≤1%
 
Application
Hexyl nicotinate can be used as an intermediate in pharmaceutical synthesis.
This product has the effect of decomposing fat and reducing local fat. The main component of fat is fatty acid triglycerides. This product can be broken down into glycerin and fatty acids through skin penetration, which makes the skin slightly warm and red, thereby reducing cellulite. Of water and facilitates the removal of fatty acids from these tissues.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Hexyl nicotinoate


Related News: The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.2-Bromo-3-Chloro-5-(Trifluoromethyl)Pyridine The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.173194-95-1 Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.757251-39-1 Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.

Related Products
Product Name
2-bromo-5-nitroanisol View Details
2-Amino-4,7-dihydro-5-[2-[4-(methoxycarbonyl)phenyl]ethyl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine View Details
7-Nitro-1,2,3,4-tetrahydroquinoline View Details
cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester manufacturer 5-Amino-o-cresol manufacturer Collagen manufacturer Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate manufacturer 2-(Phenylthio)ethanol manufacturer